These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 37525354)

  • 1. Association of baseline serum cholesterol with benefits of intensive blood pressure control.
    Wang X; Feng Y; Yang L; Zhang G; Tian X; Ling Q; Tan J; Cai J
    Chin Med J (Engl); 2023 Sep; 136(17):2058-2065. PubMed ID: 37525354
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Remnant cholesterol and intensive blood pressure control in older patients with hypertension: a post hoc analysis of the STEP randomized trial†.
    Yang R; Zhang J; Yu X; Yang G; Cai J
    Eur J Prev Cardiol; 2024 Jun; 31(8):997-1004. PubMed ID: 38167928
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of serum uric acid with benefits of intensive blood pressure control.
    Wang XQ; Tan JS; Zhang SY; Zhang WL; Cai J
    Rev Esp Cardiol (Engl Ed); 2023 Aug; 76(8):635-644. PubMed ID: 36716991
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Achieved systolic blood pressure and cardiovascular outcomes in 60-80-year-old patients: the Strategy of Blood Pressure Intervention in the Elderly Hypertensive Patients (STEP) trial.
    Deng Y; Bai J; Yang X; Liu W; Guo Z; Zhang J; Huang R; Yang X; Yu C; Yu J; Guo X; Wu H; Liu P; Zhang W; Cai J
    Eur J Prev Cardiol; 2023 Aug; 30(10):1017-1027. PubMed ID: 37172116
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intensive blood pressure lowering and the risk of new-onset diabetes in patients with hypertension: a post-hoc analysis of the STEP randomized trial.
    Yang R; Zhu Y; Xu M; Tao Y; Cong W; Cai J
    Eur J Prev Cardiol; 2023 Aug; 30(10):988-995. PubMed ID: 37036035
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of Baseline Diastolic Blood Pressure on Effects of Intensive Compared With Standard Blood Pressure Control.
    Beddhu S; Chertow GM; Cheung AK; Cushman WC; Rahman M; Greene T; Wei G; Campbell RC; Conroy M; Freedman BI; Haley W; Horwitz E; Kitzman D; Lash J; Papademetriou V; Pisoni R; Riessen E; Rosendorff C; Watnick SG; Whittle J; Whelton PK;
    Circulation; 2018 Jan; 137(2):134-143. PubMed ID: 29021322
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Baseline Predictors of Low-Density Lipoprotein Cholesterol and Systolic Blood Pressure Goal Attainment After 1 Year in the ISCHEMIA Trial.
    Newman JD; Alexander KP; Gu X; O'Brien SM; Boden WE; Govindan SC; Senior R; Moorthy N; Rezende PC; Demkow M; Lopez-Sendon JL; Bockeria O; Pandit N; Gosselin G; Stone PH; Spertus JA; Stone GW; Fleg JL; Hochman JS; Maron DJ
    Circ Cardiovasc Qual Outcomes; 2019 Nov; 12(11):e006002. PubMed ID: 31718297
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of baseline systolic blood pressure on the relationship between intensive blood pressure control and cardiovascular outcomes in the Systolic Blood Pressure Intervention Trial (SPRINT).
    Sun X; Guo Y; Nie Z; Cheng J; Zhou H; Zhong X; Zhang S; Du Z; Zhuang X; Liao X
    Clin Res Cardiol; 2019 Mar; 108(3):273-281. PubMed ID: 30167807
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atherogenic Lipoprotein Subfractions Determined by Ion Mobility and First Cardiovascular Events After Random Allocation to High-Intensity Statin or Placebo: The Justification for the Use of Statins in Prevention: An Intervention Trial Evaluating Rosuvastatin (JUPITER) Trial.
    Mora S; Caulfield MP; Wohlgemuth J; Chen Z; Superko HR; Rowland CM; Glynn RJ; Ridker PM; Krauss RM
    Circulation; 2015 Dec; 132(23):2220-9. PubMed ID: 26408274
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of baseline arterial stiffness on effects of intensive compared with standard blood pressure control: a post hoc analysis of the STEP trial.
    Song Q; Ling Q; Bai J; Zhang H; Bu P; Chen F; Wu S; Zhang W; Chen M; Cai J
    BMC Med; 2022 Oct; 20(1):358. PubMed ID: 36261812
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differing predictive relationships between baseline LDL-C, systolic blood pressure, and cardiovascular outcomes.
    Deedwania PC; Pedersen TR; DeMicco DA; Breazna A; Betteridge DJ; Hitman GA; Durrington P; Neil A;
    Int J Cardiol; 2016 Nov; 222():548-556. PubMed ID: 27513651
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A U-shaped association between the LDL-cholesterol to HDL-cholesterol ratio and all-cause mortality in elderly hypertensive patients: a prospective cohort study.
    Yu Y; Li M; Huang X; Zhou W; Wang T; Zhu L; Ding C; Tao Y; Bao H; Cheng X
    Lipids Health Dis; 2020 Nov; 19(1):238. PubMed ID: 33183311
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Baseline blood pressure, low- and high-density lipoproteins, and triglycerides and the risk of vascular events in the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial.
    Amarenco P; Goldstein LB; Callahan A; Sillesen H; Hennerici MG; O'Neill BJ; Rudolph AE; Simunovic L; Zivin JA; Welch KM;
    Atherosclerosis; 2009 Jun; 204(2):515-20. PubMed ID: 18962621
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of Lipid Levels With the Prevalence of Hypertension in Chinese Women: A Cross-Sectional Study Based on 32 Health Check Centers.
    Deng G; Li Y; Cheng W
    Front Endocrinol (Lausanne); 2022; 13():904237. PubMed ID: 35873005
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mobile phone-based interventions for improving adherence to medication prescribed for the primary prevention of cardiovascular disease in adults.
    Palmer MJ; Barnard S; Perel P; Free C
    Cochrane Database Syst Rev; 2018 Jun; 6(6):CD012675. PubMed ID: 29932455
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intensive vs Standard Blood Pressure Control in Adults 80 Years or Older: A Secondary Analysis of the Systolic Blood Pressure Intervention Trial.
    Pajewski NM; Berlowitz DR; Bress AP; Callahan KE; Cheung AK; Fine LJ; Gaussoin SA; Johnson KC; King J; Kitzman DW; Kostis JB; Lerner AJ; Lewis CE; Oparil S; Rahman M; Reboussin DM; Rocco MV; Snyder JK; Still C; Supiano MA; Wadley VG; Whelton PK; Wright JT; Williamson JD
    J Am Geriatr Soc; 2020 Mar; 68(3):496-504. PubMed ID: 31840813
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of a fixed-dose combination strategy on adherence and risk factors in patients with or at high risk of CVD: the UMPIRE randomized clinical trial.
    Thom S; Poulter N; Field J; Patel A; Prabhakaran D; Stanton A; Grobbee DE; Bots ML; Reddy KS; Cidambi R; Bompoint S; Billot L; Rodgers A;
    JAMA; 2013 Sep; 310(9):918-29. PubMed ID: 24002278
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Are polygenic risk scores for systolic blood pressure and LDL-cholesterol associated with treatment effectiveness, and clinical outcomes among those on treatment?
    Tapela NM; Collister J; Liu X; Clifton L; Stiby A; Murgia F; Hopewell JC; Hunter DJ
    Eur J Prev Cardiol; 2022 May; 29(6):925-937. PubMed ID: 34864974
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Influence of baseline glycemic status on the effects of intensive blood pressure lowering: Results from the STEP randomized trial.
    Yang R; Wang Y; Tong A; Yu J; Zhao D; Cai J
    Eur J Intern Med; 2023 Jul; 113():75-82. PubMed ID: 37142449
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Associations between remnant lipoprotein cholesterol and central systolic blood pressure in a Chinese community-based population: a cross-sectional study.
    Li K; Fan F; Zheng B; Jia J; Liu B; Liu J; Chen C; Zhou J; Zhang Y; Huo Y
    Lipids Health Dis; 2021 Jun; 20(1):60. PubMed ID: 34174876
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.